Cropnosys India Announces Successful Capital Raise of INR 375 crore

Spread the love

Cropnosys (India) PrivateBengaluru, Karnataka Dec 14, 2023 (Issuewire.com) – Limited (“Cropnosys”), an agrochemical manufacturing company that focuses on niche off patented molecules is set for a capacity expansion in Vapi, Gujarat. The new facility that is being set up will multiply the production capacity by fivefold.

“This investment into our organization strengthens our mission to strive for better control over the product and supply chain with a world class backwardly integrated plant. Though the company in 2022 doubled its previous capacity from 1200MT to 2400 MT without any external capital, the new facility to come up in Dec 2024 will add to our growth story in newer molecules and independence from sourcing key intermediates”, said Gurvinder Singh, MD of Cropnosys. He further added, “We’re elated to begin a relationship with Kotak Strategic Situations Fund, which shares the same vision: Transforming agchem supply chain.”

Cropnosys’ focus includes expanding product portfolio along with inviting global agchem partners to custom manufacturing opportunities with its semi-automated multipurpose plant driving quality and cost efficiencies. With upcoming good growth years for Cropnosys, this funding will allow it to invest in infrastructure, technology, regulatory, and people to drive the expansion in a sustainable and green way.

About Kotak Alternate Asset Managers Ltd.

Kotak Alternate Asset Managers Limited (“KAAML”), a part of Kotak Mahindra Group (“Kotak”), focuses on alternate assets management and investment advisory businesses. KAAML was set up in early 2005 and has raised/managed/advised over US$ 18 billion across different asset classes including Private Equity, Real Estate, Infrastructure, Special Situations, Private Credit and Investment Advisory. The asset management business and investment advisory vertical are managed by independent specialist teams.

For more information, visit https://alternateassets.kotak.com/

About Kotak Strategic Situations India Fund II

Kotak Strategic Situations India Fund II (“KSSF II”) is an Alternative Investment Fund under SEBI regulations managed by Kotak Alternate Asset Managers Ltd. KSSF II currently has announced the first close of USD 1.25 billion (approximately Rs 10,200 crore) to provide a strategic solution capital across growth and value companies. With a target to raise USD 1.6 billion corpus, the fund is uniquely positioned to provide customized solutions capital to corporates. KSSF II aims to partner with companies across sectors via customized structures/solutions depending on their situation, requirements and business prospects. With an ability to participate tactically across the capital structure of an enterprise, KSSF II has been targeting value propositions across a spectrum of opportunities, from growth to credit situations.

About Cropnosys (India) Private Limited

Cropnosys (India) Private Limited (“Cropnosys”) is a crop protection molecule manufacturer offering a full range of products and custom synthesis to the agrochemical industry. Our value-added custom synthesis and efficient processing solutions make us an ideal partner to leading multinational agrochemical companies.

We have multiple state-of-the-art multi-purpose plants in Vapi, Gujarat for the synthesis of intermediates and active ingredients which are designed for both contract manufacturing and feeding its associate companies with supply.

Founded in 2006, Cropnosys has come a long way in capturing markets in five (5) continents. The team is robust and well experienced, vowed to the success of the Cropnosys. Relationships built across the continents over the years give us confidence/edge to the next level of growth.

For more information visit https://www.cropnosysindia.com/

Media Contact

Cropnosys (India) Private Limited

[email protected]

+91-80-29562922

9th Floor, Arliga Northstar, Yelahanka

http://www.cropnosysindia.com

Source :Cropnosys (India) Pvt Ltd

This article was originally published by IssueWire. Read the original article here.


comtex tracking

COMTEX_444934631/2777/2023-12-14T08:43:19

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Insta Daily News journalist was involved in the writing and production of this article.